85.29

0.90% 0.76

Globus Medical Inc (GMED)

Overview News Price History Option Chain Financials Discussions Forecast

Globus Medical Inc stock is traded at $85.29, with a volume of 682.63K. It is up +0.90% in the last 24 hours and up +16.56% over the past month. Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

Previous Close:

$84.53

Open:

$84.85

24h Volume:

682.63K

Relative Volume:

0.87

Market Cap:

$11.51B

Revenue:

$2.48B

Net Income/Loss:

$91.51M

P/E Ratio:

42.43

EPS:

2.01

Net Cash Flow:

$293.77M

1W Performance:

+2.03%

1M Performance:

+16.56%

6M Performance:

+29.58%

1Y Performance:

+85.13%

1-Day Range:

$84.44

$85.74

1-Week Range:

$83.08

$85.74

52-Week Range:

$44.02

$85.74

Globus Medical Inc Stock (GMED) Company Profile

Name

Globus Medical Inc

Sector

Healthcare (1200)

Industry

Medical Devices (153)

Phone

610-930-1800

Address

2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA

Employee

5,000

Twitter

@GlobusMedical

Next Earnings Date

2024-11-05

Latest SEC Filings

GMED's Discussions on Twitter

Compare GMED with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GMED Globus Medical Inc	85.29	11.51B	2.48B	91.51M	293.77M	2.01
ABT Abbott Laboratories	118.95	208.18B	41.22B	5.77B	6.49B	2.94
SYK Stryker Corp	388.14	148.70B	21.97B	3.59B	3.21B	6.74
BSX Boston Scientific Corp	90.75	133.32B	15.91B	1.79B	1.89B	0.82
MDT Medtronic Plc	86.27	111.27B	33.00B	4.29B	5.50B	2.71
EW Edwards Lifesciences Corp	72.07	42.66B	6.60B	4.16B	490.10M	2.34

Globus Medical Inc Stock (GMED) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-07-24	Upgrade	Wells Fargo	Equal Weight → Overweight
May-20-24	Upgrade	Piper Sandler	Neutral → Overweight
Mar-18-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	ROTH MKM	Buy
Sep-19-23	Upgrade	Stifel	Hold → Buy
Mar-30-23	Upgrade	Canaccord Genuity	Hold → Buy
Feb-13-23	Downgrade	BofA Securities	Buy → Underperform
Feb-10-23	Downgrade	BTIG Research	Buy → Neutral
Feb-10-23	Downgrade	Loop Capital	Buy → Hold
Feb-10-23	Downgrade	Needham	Buy → Hold
Feb-10-23	Downgrade	Truist	Buy → Hold
Feb-10-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Buy
Apr-13-22	Resumed	Truist	Buy
Mar-28-22	Initiated	Wells Fargo	Overweight
Jan-04-22	Upgrade	Piper Sandler	Neutral → Overweight
Dec-13-21	Upgrade	BofA Securities	Underperform → Buy
Dec-10-21	Initiated	RBC Capital Mkts	Outperform
Oct-29-21	Initiated	Loop Capital	Buy
Feb-18-21	Resumed	Needham	Buy
Dec-08-20	Initiated	Citigroup	Buy
Oct-20-20	Initiated	Stifel	Hold
Aug-06-20	Reiterated	Needham	Buy
Aug-06-20	Upgrade	Northland Capital	Market Perform → Outperform
Jul-21-20	Initiated	Northland Capital	Market Perform
Jul-06-20	Downgrade	Piper Sandler	Overweight → Neutral
May-08-20	Reiterated	Needham	Buy
Mar-18-20	Upgrade	BTIG Research	Neutral → Buy
Jan-08-20	Initiated	SunTrust	Buy
Dec-12-19	Upgrade	Wells Fargo	Market Perform → Outperform
Aug-02-19	Reiterated	Needham	Buy
May-24-19	Downgrade	Wells Fargo	Outperform → Market Perform
May-03-19	Reiterated	Needham	Buy
Feb-28-19	Upgrade	UBS	Neutral → Buy
Jan-02-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-02-18	Reiterated	Needham	Buy
Jun-27-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jun-01-18	Initiated	Cantor Fitzgerald	Overweight
May-03-18	Reiterated	Needham	Buy
Apr-04-18	Upgrade	Needham	Hold → Buy

View All

Globus Medical Inc Stock (GMED) Latest News

Nov 26, 2024

GMED (Globus Medical) Operating Cash Flow per Share : $3.02 (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

GMED (Globus Medical) Revenue : $2,479 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

GMED (Globus Medical) Land And Improvements : $10 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Swedbank AB Has $28.62 Million Stock Position in Globus Medical, Inc. (NYSE:GMED) - MarketBeat

Nov 26, 2024

Massachusetts Financial Services Co. MA Buys Shares of 369,102 Globus Medical, Inc. (NYSE:GMED) - MarketBeat

Nov 26, 2024

Globus Medical, Inc. (NYSE:GMED) Shares Acquired by Intech Investment Management LLC - MarketBeat

Nov 26, 2024

Nov 25, 2024

Globus Medical director David Davidar sells shares for $3.4 million By Investing.com - Investing.com Australia

Nov 25, 2024

Globus Medical's SWOT analysis: stock soars on merger synergies, FDA hurdles loom - Investing.com

Nov 25, 2024

Globus Medical CEO Scavilla sells $11.05 million in stock By Investing.com - Investing.com Australia

Nov 25, 2024

Globus Medical CEO Scavilla sells $11.05 million in stock - Investing.com

Nov 25, 2024

Globus Medical director David Davidar sells shares for $3.4 million - Investing.com

Nov 25, 2024

GMED (Globus Medical) Peter Lynch Fair Value : $28.96 (As of Nov. 25, 2024) - GuruFocus.com

Nov 25, 2024

GMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub - Yahoo Finance

Nov 25, 2024

Nov 24, 2024

GMED (Globus Medical) Operating Income : $169 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 24, 2024

Quest Partners LLC Invests $523,000 in Globus Medical, Inc. (NYSE:GMED) - MarketBeat

Nov 24, 2024

Nov 23, 2024

Eagle Asset Management Inc. Purchases 29,573 Shares of Globus Medical, Inc. (NYSE:GMED) - MarketBeat

Nov 23, 2024

Globus Medical, Inc. (NYSE:GMED) Receives $88.18 Consensus PT from Analysts - MarketBeat

Nov 23, 2024

Nov 22, 2024

Globus Medical Launches ExcelsiusHub™ Navigation System - The Manila Times

Nov 22, 2024